02.15.08
ConMed Corp., a Utica, NY-based manufacturer of surgical devices used in arthroscopy, electrosurgery and other orthopedic and sports medicine applications, announced that the president of its Linvatec subsidiary has resigned as of Jan. 30.
Gerald G. Woodard leaves ConMed to head up SRI Surgical, a publicly traded company that provides central processing and supply chain management services to hospitals and surgery centers.
“This is a wonderful opportunity for Gerald, and all of us within the ConMed organization wish him success in his future endeavors,” said Joseph J. Corasanti, CEO and president of ConMed Corp. “Over the past seven years, Gerald has supervised the company’s orthopedic product offering and developed an organization built on customer service. We are confident that this change will have no material affect on our business, and I look forward to working closely with our orthopedic team while we search for the most appropriate candidate.”
Corasanti will oversee management of Largo, FL-based Linvatec until a replacement is found for Woodard.
Warsaw, IN-based Symmetry Medical, a provider of orthopedic implants, instruments and cases, has expanded its board of directors to seven members with the addition of John S. Krelle and Craig B. Reynolds.
Krelle is president, CEO and a member of the board of directors of FzioMed, Inc., a privately held medical biomaterials company based in San Luis Obispo, CA. (FzioMed’s technology is used in spine/ orthopedic surgery, general surgery and aesthetic surgery.) During Krelle’s career, he also spent nearly 20 years serving in various senior international positions at Zimmer Holdings, Inc., including president of Asian-based operations in Japan.
Reynolds is chief operating officer and a member of the board of directors of Respironics, Inc., a manufacturer of sleep medicine, intensive care ventilation, patient monitoring and respiratory drug delivery products. Prior to his tenure with Respironics (which struck a deal in December to be acquired by Royal Philips Electronics NV for about $5.1 billion), Reynolds worked for Healthdyne Inc. from 1981 to 1998, serving for five years as CEO and a board member.
“The increased size of our board is most welcome and should provide more valuable input to meet the growing requirements of our business,” said Brian Moore, president and CEO of Symmetry Medical. “We particularly look forward to working with John and Craig as they bring direct relevant industry experience and considerable international operational knowledge, particularly in Asia, which will be most useful to strengthen and develop our global strategy.”
The Orthopaedic Trauma and Clinical Therapies Global Business Unit of Smith & Nephew has gained a new vice president. Dwayne Montgomery will serve as vice president and general manager of Trauma Fixation. Along with this announcement, the British manufacturer of orthopedic implants and other devices has promoted Bill Shopoff to senior vice president of international business.
Montgomery previously was senior vice president of sales and sales operations for the company’s Trauma Fixation unit. In his new role, he will provide global leadership and direction for the Trauma Fixation business. Montgomery also will be responsible for overseeing sales in the United States and Canada, and will provide direction to Global Strategic Marketing, including US Downstream Marketing, and Global Product Development.
“Dwayne's professional drive and cumulative sales and leadership experiences provide the focus needed to enhance our Trauma Fixation business,” said Mark Augusti, president, Orthopaedic Trauma & Clinical Therapies.
Shopoff, who was vice president for Medical Education and Professional Affairs for the business unit prior to his promotion, now will lead all sales activities outside the United States for Trauma Fixation and Clinical Therapies to enhance the business unit’s international competitive position. He also will oversee the Earnings Improvement Program plans for these markets.
“Bill’s sales experience and strong customer relationships will help further develop and grow our international business. Additionally, his ability to evaluate and implement change will ensure the most effective operation of our sales activities in various international regions,” Augusti said.
San Diego, CA-based SpineOvations has named Robert R. Anglea to its board of directors.
Anglea, who most recently served as president of PerMedics, Inc., has spent 26 years working with healthcare technology businesses, including two Fortune 500 companies and three successful launches of emerging healthcare organizations. Prior to his position with PerMedics, he served as president of strategic direction and as president of Kendall McGaw Pharmaceuticals, where he was the corporate founder of that company’s injectable pharmaceuticals business. Earlier in his career, Anglea held various management positions with American Hospital Supply.
Anglea also has been directly involved in more than a dozen acquisitions (from both sides of the table) of health-related organizations.
“Rob has a unique eye for potential in healthcare-related businesses,” said M. Ross Simmonds, CEO of SpineOvations. “His experience as a builder of strategic partnerships, market targeting, corporate finance in our sector and focused goal direction with bottom-line orientation is sure to be a great asset to our company. We’re confident his guidance as part of our board will be a tremendous asset as we move forward into the rapidly evolving spine device marketplace.”
SpineOvations is a developer of biocompatible injectables for the stabilization of spinal disc integrity and for other orthopedic applications, including non-surgical connective tissue repair. The company’s technology platform consists of a non-surgical application for identifying and treating spinal discs that have tears or fissures in order to seal the defect and improve structural integrity.
Gerald G. Woodard leaves ConMed to head up SRI Surgical, a publicly traded company that provides central processing and supply chain management services to hospitals and surgery centers.
“This is a wonderful opportunity for Gerald, and all of us within the ConMed organization wish him success in his future endeavors,” said Joseph J. Corasanti, CEO and president of ConMed Corp. “Over the past seven years, Gerald has supervised the company’s orthopedic product offering and developed an organization built on customer service. We are confident that this change will have no material affect on our business, and I look forward to working closely with our orthopedic team while we search for the most appropriate candidate.”
Corasanti will oversee management of Largo, FL-based Linvatec until a replacement is found for Woodard.
Symmetry Medical Adds New Board Members
Warsaw, IN-based Symmetry Medical, a provider of orthopedic implants, instruments and cases, has expanded its board of directors to seven members with the addition of John S. Krelle and Craig B. Reynolds.
Krelle is president, CEO and a member of the board of directors of FzioMed, Inc., a privately held medical biomaterials company based in San Luis Obispo, CA. (FzioMed’s technology is used in spine/ orthopedic surgery, general surgery and aesthetic surgery.) During Krelle’s career, he also spent nearly 20 years serving in various senior international positions at Zimmer Holdings, Inc., including president of Asian-based operations in Japan.
Reynolds is chief operating officer and a member of the board of directors of Respironics, Inc., a manufacturer of sleep medicine, intensive care ventilation, patient monitoring and respiratory drug delivery products. Prior to his tenure with Respironics (which struck a deal in December to be acquired by Royal Philips Electronics NV for about $5.1 billion), Reynolds worked for Healthdyne Inc. from 1981 to 1998, serving for five years as CEO and a board member.
“The increased size of our board is most welcome and should provide more valuable input to meet the growing requirements of our business,” said Brian Moore, president and CEO of Symmetry Medical. “We particularly look forward to working with John and Craig as they bring direct relevant industry experience and considerable international operational knowledge, particularly in Asia, which will be most useful to strengthen and develop our global strategy.”
Smith & Nephew Promotes Two of Its Own
The Orthopaedic Trauma and Clinical Therapies Global Business Unit of Smith & Nephew has gained a new vice president. Dwayne Montgomery will serve as vice president and general manager of Trauma Fixation. Along with this announcement, the British manufacturer of orthopedic implants and other devices has promoted Bill Shopoff to senior vice president of international business.
Montgomery previously was senior vice president of sales and sales operations for the company’s Trauma Fixation unit. In his new role, he will provide global leadership and direction for the Trauma Fixation business. Montgomery also will be responsible for overseeing sales in the United States and Canada, and will provide direction to Global Strategic Marketing, including US Downstream Marketing, and Global Product Development.
“Dwayne's professional drive and cumulative sales and leadership experiences provide the focus needed to enhance our Trauma Fixation business,” said Mark Augusti, president, Orthopaedic Trauma & Clinical Therapies.
Shopoff, who was vice president for Medical Education and Professional Affairs for the business unit prior to his promotion, now will lead all sales activities outside the United States for Trauma Fixation and Clinical Therapies to enhance the business unit’s international competitive position. He also will oversee the Earnings Improvement Program plans for these markets.
“Bill’s sales experience and strong customer relationships will help further develop and grow our international business. Additionally, his ability to evaluate and implement change will ensure the most effective operation of our sales activities in various international regions,” Augusti said.
SpineOvations Names New Member to Board
San Diego, CA-based SpineOvations has named Robert R. Anglea to its board of directors.
Anglea, who most recently served as president of PerMedics, Inc., has spent 26 years working with healthcare technology businesses, including two Fortune 500 companies and three successful launches of emerging healthcare organizations. Prior to his position with PerMedics, he served as president of strategic direction and as president of Kendall McGaw Pharmaceuticals, where he was the corporate founder of that company’s injectable pharmaceuticals business. Earlier in his career, Anglea held various management positions with American Hospital Supply.
Anglea also has been directly involved in more than a dozen acquisitions (from both sides of the table) of health-related organizations.
“Rob has a unique eye for potential in healthcare-related businesses,” said M. Ross Simmonds, CEO of SpineOvations. “His experience as a builder of strategic partnerships, market targeting, corporate finance in our sector and focused goal direction with bottom-line orientation is sure to be a great asset to our company. We’re confident his guidance as part of our board will be a tremendous asset as we move forward into the rapidly evolving spine device marketplace.”
SpineOvations is a developer of biocompatible injectables for the stabilization of spinal disc integrity and for other orthopedic applications, including non-surgical connective tissue repair. The company’s technology platform consists of a non-surgical application for identifying and treating spinal discs that have tears or fissures in order to seal the defect and improve structural integrity.